Charbel Nassar

The Gluten-Free Brief: Policy, science, global developments.

AI-Assisted Biopsy Diagnosis, Historical Misdiagnosis in Norway, and Screen-Detected Celiac Outcomes | The Gluten-Free Brief – August 21, 2026

A Cleveland Clinic AI model reaches 97% accuracy distinguishing celiac from normal biopsies, while a Norwegian study finds evidence of historical misdiagnosis. Plus long-term outcomes, COVID-19 risk and recalls.

AI-Assisted Biopsy Diagnosis, Historical Misdiagnosis in Norway, and Screen-Detected Celiac Outcomes | The Gluten-Free Brief – August 21, 2026 Read More »

The Gluten-Free Brief: Policy, science, global developments.

Tunisia’s Gluten-Free Funding Boost, UK Diagnosis Update, and a New Global “May Contain” Standard | The Gluten-Free Brief – July 21, 2026

Tunisia funds gluten-free diets, Codex sets a global “may contain” gluten standard, and the UK updates celiac diagnosis guidance. Plus recalls.

Tunisia’s Gluten-Free Funding Boost, UK Diagnosis Update, and a New Global “May Contain” Standard | The Gluten-Free Brief – July 21, 2026 Read More »

The Gluten-Free Brief: News from six countries in one quick read.

Stroke Patient Repeatedly Served Gluten, New Celiac Disease Research, and UK & France Recalls | The Gluten-Free Brief – July 7, 2026

The latest gluten-free news from around the world: a New Zealand hospital case, new celiac disease research from Norway, advocacy stories from Malta and Spain, and recent gluten-related recalls in the UK and France.

Stroke Patient Repeatedly Served Gluten, New Celiac Disease Research, and UK & France Recalls | The Gluten-Free Brief – July 7, 2026 Read More »